Why did Gilead Sciences stock rise on 9 October?
Written after the close on
Gilead Sciences +2.77%
Gilead rises sharply on upbeat revenue and a raised target. Over the last five trading days Gilead Sciences climbed steeply, outpacing both the broader market and the healthcare sector, which also advanced. Watch the late-October earnings report, when analysts expect lower profit on roughly flat revenue.
Next report: · Add to calendar · Google Calendar